Tag: therapeutics

23andMe’s CEO Featured On The Today Show

As part of a series on cutting edge women, The Today Show featured Anne Wojcicki, 23andMe's CEO and co-founder. The NBC crew followed Anne as she hustled through a typical day, juggling family life, and work meetings. The crew also got a glimpse of 23andMe's Therapeutics lab, and sat down with her to talk ...

Read more

Find Us At ASHG

Attending the annual American Society of Human Genetics meeting in Vancouver next week? We'd love to hear from you! Attend our talks, come by our posters, and find us at our booth. The 23andMe research team has a full slate of presentations and posters at ASHG this year. Wednesday, Oct 19 TALK 11:30am ...

Read more

23andMe Scientists To Present New Findings

23andMe scientists will be at the annual American Society of Human Genetics meeting in Vancouver this month sharing a wide spectrum of interesting data that includes more on the genetics of Parkinson’s disease, promising new methods for drug discovery, and even some fun findings around traits like nail biting ...

Read more

What’s New In Parkinson’s Research

From implanting cells into the brain to prevent the loss of dopamine producing nerve cells, to placing light sensitive channels in nerve cells to better treat the symptoms of Parkinson’s disease, researchers are pushing into new realms in the fight against the disease. At the ninth annual Michael J. Fox ...

Read more

Richard Scheller Named to National Academy of Medicine

Growing up 23andMe’s chief science officer Richard Scheller, Ph.D., had classmates in his elementary school, who wanted to be a firemen, police officers and astronauts. Richard always wanted to be a scientist. “My classmates had posters of rock bands or cars on the walls in their bedrooms,” he said. “I ...

Read more

The Future of Health Care

Anne Wojcicki, 23andMe's CEO and co-founder, spoke recently with Kai Ryssdal, the host and senior editor at Marketplace, about the company, genetics, and the future of health care. It's a good overview of some of what we've been doing lately here at 23andMe. Anne takes time to explain some of 23andMe's ...

Read more

A Computational Biologist And A Gentleman

Over the last few months 23andMe has assembled a virtual dream team to make up its therapeutics group. Starting with the appointment of Richard Scheller, Ph.D. as chief science officer and head of therapeutics, 23andMe has filled out the team with some top-notch talent including another luminary Robert ...

Read more

Return to top